WO2014128728A3 - Solid forms of cabazitaxel and processes for preparation thereof - Google Patents

Solid forms of cabazitaxel and processes for preparation thereof Download PDF

Info

Publication number
WO2014128728A3
WO2014128728A3 PCT/IN2014/000114 IN2014000114W WO2014128728A3 WO 2014128728 A3 WO2014128728 A3 WO 2014128728A3 IN 2014000114 W IN2014000114 W IN 2014000114W WO 2014128728 A3 WO2014128728 A3 WO 2014128728A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
cabazitaxel
processes
solid forms
pharmaceutical compositions
Prior art date
Application number
PCT/IN2014/000114
Other languages
French (fr)
Other versions
WO2014128728A2 (en
Inventor
Satyanarayana Chava
Seeta Ramanjaneyulu Gorantla
Venkata Sunil Kumar Indukuri
Sanjay Kumar Dehury
Nagaraju MEKALA
Srinivasa Rao BODDEPU
Siva Ramireddy BATHULA
Original Assignee
Laurus Labs Private Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laurus Labs Private Limited filed Critical Laurus Labs Private Limited
Publication of WO2014128728A2 publication Critical patent/WO2014128728A2/en
Publication of WO2014128728A3 publication Critical patent/WO2014128728A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The present invention provides solid forms of cabazitaxel, processes for its preparation and pharmaceutical compositions containing the same. The present invention also provides an amorphous form and a process for its preparation and pharmaceutical compositions thereof.
PCT/IN2014/000114 2013-02-25 2014-02-21 Solid forms of cabazitaxel and processes for preparation thereof WO2014128728A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN799CH2013 2013-02-25
IN799/CHE/2013 2013-02-25
IN3754/CHE/2013 2013-08-26
IN3754CH2013 2013-08-26

Publications (2)

Publication Number Publication Date
WO2014128728A2 WO2014128728A2 (en) 2014-08-28
WO2014128728A3 true WO2014128728A3 (en) 2014-12-04

Family

ID=51391941

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2014/000114 WO2014128728A2 (en) 2013-02-25 2014-02-21 Solid forms of cabazitaxel and processes for preparation thereof

Country Status (1)

Country Link
WO (1) WO2014128728A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3402510A4 (en) 2016-01-15 2019-02-20 Zhuhai Beihai Biotech Co., Ltd. Compositions and formulations including cabazitaxel and human serum albumin
CN117205305B (en) 2018-04-20 2024-04-26 珠海贝海生物技术有限公司 Formulations and compositions of cabazitaxel
CN113429369B (en) * 2021-07-23 2022-12-02 无锡紫杉药业有限公司 Efficient cabazitaxel purification method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
WO2009115655A2 (en) * 2008-01-17 2009-09-24 Aventis Pharma S.A. Crystalline forms of dimethoxy docetaxel and methods for preparing same
WO2012142117A1 (en) * 2011-04-12 2012-10-18 Plus Chemicals Sa Solid state forms of cabazitaxel and processes for preparation thereof
CN102746258A (en) * 2012-07-25 2012-10-24 重庆泰濠制药有限公司 Crystal forms of cabazitaxel and preparation method thereof
WO2013134534A2 (en) * 2012-03-08 2013-09-12 Plus Chemicals S.A. Solid state forms of cabazitaxel and processes for preparation thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
WO2009115655A2 (en) * 2008-01-17 2009-09-24 Aventis Pharma S.A. Crystalline forms of dimethoxy docetaxel and methods for preparing same
WO2012142117A1 (en) * 2011-04-12 2012-10-18 Plus Chemicals Sa Solid state forms of cabazitaxel and processes for preparation thereof
WO2013134534A2 (en) * 2012-03-08 2013-09-12 Plus Chemicals S.A. Solid state forms of cabazitaxel and processes for preparation thereof
CN102746258A (en) * 2012-07-25 2012-10-24 重庆泰濠制药有限公司 Crystal forms of cabazitaxel and preparation method thereof

Also Published As

Publication number Publication date
WO2014128728A2 (en) 2014-08-28

Similar Documents

Publication Publication Date Title
EP3642182A4 (en) Compounds, compositions and methods for synthesis
EP3356595A4 (en) Processes for producing nanocellulose, and nanocellulose compositions produced therefrom
EP3436482A4 (en) Antibodies, pharmaceutical compositions and methods
ZA201604831B (en) Hybridosomes, compositions comprising the same, processes for their production and uses thereof
EP3259272A4 (en) Fused-ring compounds, pharmaceutical composition and uses thereof
EP3209653A4 (en) Process for the preparation of (r,s)-nicotine
EP3129048A4 (en) Antibodies, pharmaceutical compositions and uses thereof
WO2015051030A8 (en) Stabilized polypeptides and uses thereof
EP3140305A4 (en) Novel compositions, uses and methods for making them
EP3160921A4 (en) Process for the preparation of humic extracts from fossil sources
EP3504196A4 (en) Processes for preparing olaparib
EP3359193A4 (en) Novel carbohydrate antibodies, pharmaceutical compositions and uses thereof
WO2014162320A3 (en) Novel analogues of epicatechin and related polyphenols
WO2013080217A3 (en) Crystalline forms of carbazitaxel and process for preparation thereof
WO2013164839A3 (en) Amorphous form of apixaban, process of preparation and compositions thereof
WO2015191945A3 (en) Solid state forms of sofosbuvir
EP2978420A4 (en) Stable nanocomposition comprising paclitaxel, process for the preparation thereof, its use and pharmaceutical compositions containing it
MX2016008369A (en) Pharmaceutical composition containing palonosetron.
EP3310439A4 (en) Pharmaceutical compositions for anesthesiological applications
IL249872A0 (en) Amorphous form of eliglustat hemitartarate, compositions containing same and processes for producing same
WO2015092810A3 (en) Amorphous form of idelalisib
EP3013145A4 (en) Tetrahydrofuran-2,5-dicarbaldehydes (diformyl-tetrahydrofuran, dfthf) and process for making the same
WO2014091167A3 (en) Cyclopropylboronic compounds, method for preparing same and use thereof
EP3313393A4 (en) Platinum compounds, compositions, and uses thereof
IN2014CH00840A (en)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14754184

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 14754184

Country of ref document: EP

Kind code of ref document: A2